Helen Sheridan

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

Long Covid, Antimicrobial Stewardship, Antibiotics +7

Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D- CFTR mutation and preserved spirometry: a randomised controlled trial

Jane C. Davies, Helen Sheridan, Nicholas Bell et al. · The Lancet Respiratory Medicine · 2013 · 221 citations

Pulmonary Care, Advanced Lung Disease, Cystic Fibrosis Patients +7

Dose-dependent relationship between acidosis at birth and likelihood of death or cerebral palsy

Rod Kelly, SM Ramaiah, Helen Sheridan et al. · Archives of Disease in Childhood Fetal & Neonatal · 2017 · 39 citations · Full text

Supine posture changes lung volumes and increases ventilation heterogeneity in cystic fibrosis

Laurie Smith, Kenneth Macleod, Guilhem Collier et al. · PLoS ONE · 2017 · 12 citations · Full text

WS7.6 Effect of ivacaftor on lung function in subjects with CF who have the G551D-CFTR mutation and mild lung disease: a comparison of lung clearance index (LCI) vs. spirometry

Jane C. Davies, Helen Sheridan, P.-S. Lee et al. · Journal of Cystic Fibrosis · 2012 · 10 citations · Full text

Ws7.6 Effect, Advanced Lung Disease, Pulmonary Physiology +7